礼来：口服减肥药减重近12%，股价盘前跳水逾13%

和讯网08-07

【礼来口服减肥药Orforglipron试验结果公布，股价盘前跳水】 当地时间周四，美国医药巨头礼来宣布，后期试验数据显示，口服减肥药Orforglipron持续服用逾一年，可让受试者体重下降近12%。 这一结果虽为上市申请清除关键障碍，但逊于华尔街此前预期的减重13% - 15%。数据发布后，礼来股价在盘前跳水逾13%。 摩根士丹利分析师曾预计，若获批用于减重和2型糖尿病治疗，该药物2033年...

Source Link
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment